Trademark Overview
On Sunday, October 26, 2025, a trademark application was filed for AVEYLIUS with the United States Patent and Trademark Office. The USPTO has given the AVEYLIUS trademark a serial number of 99462901. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 2, 2026. This trademark is owned by Shanghai Henlius Biotech, Inc.. The AVEYLIUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products for the prevention and treatment of cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for cellular therapy for the treatment of cancer, tumors; Biological preparations for the prevention and treatment of cancer; Medicinal preparations for human purposes for the treatment and prevention of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for tumor; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes used by medical laboratories; Pharmaceutical preparations for the treatment and prevention of cancer, tumors; Pharmaceutical preparations for the treatment of pain; Chemical reagents for medical purposes; Pharmaceutical preparations for suppressing tumors; Chemical preparations for pharmaceutical or medical purposes, namely, for treating oncological diseases, namely, liver cancer, rectal cancer, ovarian cancer, peritoneal cance...
